Is Abbott Laboratories (ABT) Undervalued?
Based on the current stock price of $124.84 and a P/E ratio of 15.68,Abbott Laboratories has a PEG ratio of 1.46.
The Short Answer:
Most analysts consider a PEG ratio below 1.0 to be undervalued. With a ratio of 1.46, ABT appears to be fairly valued relative to its growth rate of 10.73%.
Based on a PEG ratio of 1.23 (adjusted for dividends).
Compare ABT vs Competitors
Use the calculator below to see how ABT stacks up against other stocks in the same industry.
How we analyzed ABT
We calculated the PEG (Price/Earnings-to-Growth) ratio by taking the Price-to-Earnings Ratio of 15.68and dividing it by the annual growth rate of 10.73%.
PEG = 15.68 (P/E) ÷ 10.73 (Growth) = 1.46
Frequently Asked Questions about ABT
What is the current PEG Ratio for Abbott Laboratories (ABT)?+
The current PEG Ratio for Abbott Laboratories is 1.46. A PEG ratio below 1.0 generally suggests the stock may be undervalued relative to its growth.
Is ABT stock undervalued right now?+
Based on the PEG ratio of 1.46, Abbott Laboratories appears to be fairly valued. Investors typically look for a PEG ratio below 1.0 to find undervalued growth stocks.
What is the PEGY Ratio for ABT?+
The PEGY ratio for Abbott Laboratories is 1.23. This metric accounts for dividend yield (2.02%), providing a more complete valuation picture.